Biologics for hidradenitis suppurativa
With Jennifer Hsiao, MD Products under investigation represent diverse targets “Much research remains to be done to better elucidate the pathophysiology of hidradenitis suppurativa (HS), but it is exciting that the investigational pipeline includes multiple biologic agents because it provides hope for having more therapeutic options to offer patients suffering from this disease,” said Jennifer […]